[HTML][HTML] Coronavirus vaccine development: from SARS and MERS to COVID-19
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of
coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the …
coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the …
[HTML][HTML] Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
I McDonald, SM Murray, CJ Reynolds, DM Altmann… - npj Vaccines, 2021 - nature.com
As SARS-CoV-2 vaccines are deployed worldwide, a comparative evaluation is important to
underpin decision-making. We here report a systematic literature review and meta-analysis …
underpin decision-making. We here report a systematic literature review and meta-analysis …
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine …
[HTML][HTML] Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
S Wang, B Liang, W Wang, L Li, N Feng… - Signal transduction and …, 2023 - nature.com
Human diseases, particularly infectious diseases and cancers, pose unprecedented
challenges to public health security and the global economy. The development and …
challenges to public health security and the global economy. The development and …
[HTML][HTML] A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition
ME Dieterle, D Haslwanter, RH Bortz… - Cell host & …, 2020 - cell.com
There is an urgent need for vaccines and therapeutics to prevent and treat COVID-19. Rapid
SARS-CoV-2 countermeasure development is contingent on the availability of robust …
SARS-CoV-2 countermeasure development is contingent on the availability of robust …
[HTML][HTML] Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus
Middle East respiratory syndrome (MERS) is a deadly viral respiratory disease caused by
MERS-coronavirus (MERS-CoV) infection. To date, there is no specific treatment proven …
MERS-coronavirus (MERS-CoV) infection. To date, there is no specific treatment proven …
Vaccination strategies to combat novel corona virus SARS-CoV-2
The 2019-novel coronavirus disease (COVID-19) is caused by SARS-CoV-2 is transmitted
from human to human has recently reported in China. Now COVID-19 has been spread all …
from human to human has recently reported in China. Now COVID-19 has been spread all …
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
The sudden emergence of a highly transmissible and pathogenic coronavirus SARS-CoV-2
in December 2019 from China and its rapid global spread has posed an international health …
in December 2019 from China and its rapid global spread has posed an international health …
[HTML][HTML] Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
J Bian, Z Li - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) outbreak is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Angiotensin-converting enzyme 2 …
MERS coronavirus outbreak: Implications for emerging viral infections
A Al-Omari, AA Rabaan, S Salih, JA Al-Tawfiq… - … and infectious disease, 2019 - Elsevier
In September 2012, a novel coronavirus was isolated from a patient who died in Saudi
Arabia after presenting with acute respiratory distress and acute kidney injury. Analysis …
Arabia after presenting with acute respiratory distress and acute kidney injury. Analysis …